glipizide has been researched along with glimepiride in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (22.50) | 29.6817 |
| 2010's | 25 (62.50) | 24.3611 |
| 2020's | 6 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Birkeland, KI; Bleskestad, IH | 1 |
| Jin, SH; Li, ZR; Shi, YQ; Yao, J | 1 |
| Kapoor, JR | 1 |
| Krishnarajah, G; Lyu, R; Mavros, P; Vexiau, P; Yin, D | 1 |
| Ee, JW; Kwon, SW; Lee, J; Lee, WJ; Park, JH; Shaodong, J | 1 |
| Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS | 2 |
| Heikkilä, P; Huupponen, R; Laine, K; Tirkkonen, T | 1 |
| Andersson, C; Gislason, GH; Hansen, PR; Jørgensen, CH; Køber, L; Mérie, C; Norgaard, ML; Olesen, JB; Schmiegelow, M; Sørensen, R; Torp-Pedersen, C; Vaag, A; Weeke, P | 1 |
| Burns, BD; Levine, M; Lovecchio, F; Pizon, AF; Riley, BD; Ruha, AM; Thomas, SH | 1 |
| Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH | 1 |
| Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Nutter, B; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS | 1 |
| Çapoğlu, I; Demirtaş, L; Gürbüzel, M; Halıcı, Z; Kızılet, H; Özçiçek, F | 1 |
| Del Prato, S; Nauck, M | 1 |
| He, L; Lee, J; Mendell-Harary, J; Tao, B; Walker, J; Wickremasingha, P; Wight, D | 1 |
| Bate, C; Ingham, V; Williams, A | 1 |
| Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A | 1 |
| Abdelmoneim, AS; Choi, S; Featherstone, TR; Lee, J; Simpson, SH; Vandermeer, B | 1 |
| Bilker, WB; Brensinger, CM; Cardillo, S; Flockhart, DA; Flory, JH; Gagne, JJ; Han, X; Hennessy, S; Leonard, CE | 1 |
| Chen, GM; Lu, J; Shao, H; Xu, YT; Zhan, Y; Zhang, HJ | 1 |
| Goldman, DP; Gong, C; Jena, AB; Peters, A; Romley, JA; Williams, B | 1 |
| El-Zaher, AA; Elkady, EF; Elwy, HM; Saleh, MA | 1 |
| Bilker, WB; Brensinger, CM; Chiang, C; Han, X; Hennessy, S; Leonard, CE; Li, L | 1 |
| Aquilante, CL; Bilker, WB; Boudreau, DM; Brensinger, CM; Deo, R; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Mangaali, MJ | 1 |
| Huang, HK; Yeh, JI | 1 |
| Bilker, WB; Brensinger, CM; Dawwas, GK; Dhopeshwarkar, N; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Soprano, SE | 1 |
| Chiriac, FL; Iancu, VI; Radu, GL; Scutariu, RE | 1 |
| Bilker, WB; Brensinger, CM; Flory, JH; Hee Nam, Y; Hennessy, S; Leonard, CE | 1 |
| Berry, SD; Hayes, KN; Munshi, MN; Riester, MR; Zullo, AR | 1 |
| Gayakvad, B; Kothari, C; Patel, C; Patel, R; Solanki, R; Wadhwana, P | 1 |
| Jannetto, PJ; Langman, LJ | 1 |
3 review(s) available for glipizide and glimepiride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
Mortality risk among sulfonylureas: a systematic review and network meta-analysis.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sulfonylurea Compounds | 2015 |
1 trial(s) available for glipizide and glimepiride
| Article | Year |
|---|---|
The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil.
Topics: Adult; Algorithms; Allylamine; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Area Under Curve; Colesevelam Hydrochloride; Cross-Over Studies; Delayed-Action Preparations; Drug Interactions; Female; Glipizide; Half-Life; Humans; Hypoglycemic Agents; Imidazoles; Male; Olmesartan Medoxomil; Sulfonylurea Compounds; Tetrazoles | 2014 |
36 other study(ies) available for glipizide and glimepiride
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Differences between oral antidiabetics].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Glipizide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2003 |
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds | 2007 |
Postprandial hyperglycemia: are all sulfonylureas created equal?
Topics: Carbamates; Cyclohexanes; Glipizide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Sulfonylurea Compounds | 2008 |
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; France; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Stress, Psychological; Sulfonylurea Compounds | 2008 |
Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs.
Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Light; Reproducibility of Results; Scattering, Radiation; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds | 2010 |
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Sulfonylurea Compounds | 2010 |
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Young Adult | 2010 |
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hypoglycemic Agents; Male; Sulfonylurea Compounds; Tolbutamide | 2011 |
Hypoglycemia after accidental pediatric sulfonylurea ingestions.
Topics: Accidents, Home; Arizona; Blood Glucose; Child, Preschool; Emergency Service, Hospital; Glipizide; Glucose; Glyburide; Hospitals, Pediatric; Hospitals, Teaching; Hospitals, Urban; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Infant; Poisoning; Retrospective Studies; Sulfonylurea Compounds; Time Factors | 2011 |
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds | 2012 |
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Propensity Score; Retrospective Studies; Sulfonylurea Compounds; Young Adult | 2012 |
Genotoxic evaluation of two oral antidiabetic agents in the Drosophila wing spot test.
Topics: Animals; Drosophila; Drosophila Proteins; Genes, Insect; Glipizide; Hypoglycemic Agents; Mutagenicity Tests; Mutagens; Mutation; Sulfonylurea Compounds; Wings, Animal | 2014 |
[SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!].
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glipizide; Glucosides; Glycated Hemoglobin; Glycosuria; Humans; Hypoglycemic Agents; Insulin; Metformin; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds | 2013 |
Glimepiride reduces CD14 expression and cytokine secretion from macrophages.
Topics: Amyloid beta-Peptides; Animals; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Gene Expression Regulation; Glipizide; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Lipopolysaccharide Receptors; Lipopolysaccharides; Macrophages; Membrane Microdomains; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neuroglia; Peptide Fragments; Prions; Sulfonylurea Compounds; Time Factors | 2014 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide | 2015 |
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
Topics: Aged; Algorithms; Cohort Studies; Drug Interactions; Female; Fenofibrate; Glipizide; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Incidence; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sulfonylurea Compounds | 2016 |
Metabolic Interaction Potential between Clopidogrel and Sulfonylurea Antidiabetic Agents: Effects on Clopidogrel Bioactivation.
Topics: Carboxylic Ester Hydrolases; Clopidogrel; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9 Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Gliclazide; Glipizide; Humans; Hypoglycemic Agents; Intestines; Liver; Microsomes; Sulfonylurea Compounds; Ticlopidine | 2016 |
Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Diabetes Mellitus, Type 2; Emergency Service, Hospital; Female; Glipizide; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Medicare; Retrospective Studies; Sulfonylurea Compounds; United States; Warfarin | 2015 |
Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine).
Topics: Carbamates; Chromatography, High Pressure Liquid; Drug Contamination; Glipizide; Guanidines; Hypoglycemic Agents; Metformin; Pioglitazone; Piperidines; Sulfonylurea Compounds; Thiazolidinediones | 2016 |
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.
Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Medical Informatics; Nateglinide; Pharmacoepidemiology; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2017 |
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; United States; Ventricular Dysfunction | 2018 |
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.
Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Mortality; Piperidines; Secretagogues; Sulfonylurea Compounds; Taiwan | 2019 |
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations.
Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Male; Medicaid; Middle Aged; Sulfonylurea Compounds; Treatment Outcome; United States; Ventricular Fibrillation | 2020 |
Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method.
Topics: Chromatography, Liquid; Environmental Monitoring; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Metformin; Reproducibility of Results; Solid Phase Extraction; Sulfonylurea Compounds; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2021 |
Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.
Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbamates; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Medicaid; Metformin; Middle Aged; Nateglinide; Pharmacoepidemiology; Piperidines; Secretagogues; Sulfonylurea Compounds; United States | 2022 |
Comparative safety of sulfonylureas among U.S. nursing home residents.
Topics: Aged; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Medicare; Myocardial Infarction; Nursing Homes; Retrospective Studies; Stroke; United States | 2023 |
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Metformin; Nitrosamines; Pharmaceutical Preparations; Tandem Mass Spectrometry | 2023 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |